Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update

Detalles Bibliográficos
Autores principales: Ferri, Claudio, Desideri, Giovambattista, Del Pinto, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014900/
https://www.ncbi.nlm.nih.gov/pubmed/33792849
http://dx.doi.org/10.1007/s40292-021-00446-w
_version_ 1783673581301923840
author Ferri, Claudio
Desideri, Giovambattista
Del Pinto, Rita
author_facet Ferri, Claudio
Desideri, Giovambattista
Del Pinto, Rita
author_sort Ferri, Claudio
collection PubMed
description
format Online
Article
Text
id pubmed-8014900
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80149002021-04-01 Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update Ferri, Claudio Desideri, Giovambattista Del Pinto, Rita High Blood Press Cardiovasc Prev Commentary Springer International Publishing 2021-04-01 2021 /pmc/articles/PMC8014900/ /pubmed/33792849 http://dx.doi.org/10.1007/s40292-021-00446-w Text en © Italian Society of Hypertension 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Commentary
Ferri, Claudio
Desideri, Giovambattista
Del Pinto, Rita
Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
title Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
title_full Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
title_fullStr Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
title_full_unstemmed Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
title_short Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
title_sort commentary to angiotensin-converting-enzyme 2 and renin–angiotensin system inhibitors in covid-19: an update
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014900/
https://www.ncbi.nlm.nih.gov/pubmed/33792849
http://dx.doi.org/10.1007/s40292-021-00446-w
work_keys_str_mv AT ferriclaudio commentarytoangiotensinconvertingenzyme2andreninangiotensinsysteminhibitorsincovid19anupdate
AT desiderigiovambattista commentarytoangiotensinconvertingenzyme2andreninangiotensinsysteminhibitorsincovid19anupdate
AT delpintorita commentarytoangiotensinconvertingenzyme2andreninangiotensinsysteminhibitorsincovid19anupdate

Ejemplares similares